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Late-onset Alzheimer’s disease is the most common cause of
dementia in western societies. Despite remarkable achieve-
ments in human genetics over the years, in particular, tech-
no-logical advances in gene mapping and in statistical
methods, to date only a small proportion of the genetic con-
tributiontoAlzheimer’sdiseasecanbeexplained.Onereason
for the diﬃculty in gene identiﬁcation is that Alzheimer’s
disease is a complex disorder in which multiple genes with
s m a l li n d i v i d u a le ﬀects as well as environmental factors are
likely to contribute to disease risk as well as the various
quantitative traits associated with the disease such as age-of-
onset, cognition, neuropsychiatric symptoms, amyloid/tau
pathology, or structural brain changes. Identifying the
genetic factors modulating changes in these individual en-
dophenotypes would help elucidate disease pathogenesis. In
this special issue on genetics and genomics of Alzheimer’s
disease and its endophenotypes,we have invited a few papers
t h a ta d d r e s st h i si s s u e .
The ﬁrst two articles address the impact of APOE geno-
type, the best established Alzheimer’s disease susceptibility
gene, on neuropsychiatric endophenotypes associated with
Alzheimer’s disease including psychosis, late-life depression,
anxiety, apathy, hallucinations, agitation, and aggressiveness.
The third paper examines the eﬀe c to fa ni n t r o n7p o l y -
morphism in the amyloid precursor protein (APP) on the
age of onset of Alzheimer’s disease in persons with Down
syndrome. The fourth and ﬁfth papers explore mechanisms
modulating components of the amyloid cascade pathway,
focusing, in particular, on the APP intracellular domain
(AICD), which is an end product of the proteolytic cleavage
of APP by β-a n dγ-secretase. In the ﬁrst of these two papers,
Ansaloni et al. evaluated the eﬀect of NTRK2 which encodes
the TrkB receptor on APP metabolism and AICD levels.
TrkB is a member of the tyrosine kinase receptor family
and binds speciﬁcally to brain-derived neurotrophic factor
(BDNF). The paper reports on the eﬀects of diﬀerent TrkB
isoforms on APP metabolism in the human neuroblastoma
cellline.Intheotherpaper,Raychaudhurietal.examinedthe
impact of overexpression of AICD on expression of proteins
that are part of pathways involved in neurodegeneration
and neuroregeneration. Finally, the sixth paper reviews
the ﬁndings of genome-wide association studies (GWAS)2 International Journal of Alzheimer’s Disease
that tested whether SNPs in the top-ranked Alzheimer’s
disease-related candidate genes were associated with various
brain imaging endophenotypesincluding the volumes of the
temporal lobe, hippocampus, amygdale, and frontal lobe,
as well as grey matter density, entorhinal cortex thickness,
and white matter integrity. In addition, this article discusses
multigene and more complex genetic models as a means to
identify genetic contributions to Alzheimer’s disease.
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